Gland Pharma Limited GLAND.NS Stock
Gland Pharma Limited Price Chart
Gland Pharma Limited GLAND.NS Financial and Trading Overview
| Gland Pharma Limited stock price | 1764 INR |
| Previous Close | 1008.45 INR |
| Open | 1016 INR |
| Bid | 1014.3 INR x N/A |
| Ask | 1014.95 INR x N/A |
| Day's Range | 1012 - 1027.15 INR |
| 52 Week Range | 861 - 2718 INR |
| Volume | 371.76K INR |
| Avg. Volume | 1.06M INR |
| Market Cap | 167.16B INR |
| Beta (5Y Monthly) | 0.267015 |
| PE Ratio (TTM) | 20.307123 |
| EPS (TTM) | 40.07 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1379.44 INR |
GLAND.NS Valuation Measures
| Enterprise Value | 125.91B INR |
| Trailing P/E | 20.307123 |
| Forward P/E | 14.866707 |
| PEG Ratio (5 yr expected) | 2.49 |
| Price/Sales (ttm) | 4.6119084 |
| Price/Book (mrq) | 2.099203 |
| Enterprise Value/Revenue | 3.474 |
| Enterprise Value/EBITDA | 12.287 |
Trading Information
Gland Pharma Limited Stock Price History
| Beta (5Y Monthly) | 0.267015 |
| 52-Week Change | -60.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2718 INR |
| 52 Week Low | 861 INR |
| 50-Day Moving Average | 1181.15 INR |
| 200-Day Moving Average | 1541.58 INR |
GLAND.NS Share Statistics
| Avg. Volume (3 month) | 1.06M INR |
| Avg. Daily Volume (10-Days) | 1.2M INR |
| Shares Outstanding | 164.7M |
| Float | 61.05M |
| Short Ratio | N/A |
| % Held by Insiders | 62.90% |
| % Held by Institutions | 25.52% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 21.54% |
| Operating Margin (ttm) | 24.22% |
| Gross Margin | 50.05% |
| EBITDA Margin | 28.27% |
Management Effectiveness
| Return on Assets (ttm) | 6.60% |
| Return on Equity (ttm) | 10.33% |
Income Statement
| Revenue (ttm) | 36.25B INR |
| Revenue Per Share (ttm) | 220.16 INR |
| Quarterly Revenue Growth (yoy) | -28.79% |
| Gross Profit (ttm) | N/A |
| EBITDA | 10.25B INR |
| Net Income Avi to Common (ttm) | 7.81B INR |
| Diluted EPS (ttm) | 49.98 |
| Quarterly Earnings Growth (yoy) | -72.50% |
Balance Sheet
| Total Cash (mrq) | 37.71B INR |
| Total Cash Per Share (mrq) | 229.07 INR |
| Total Debt (mrq) | 44.53M INR |
| Total Debt/Equity (mrq) | 0.06 INR |
| Current Ratio (mrq) | 9.464 |
| Book Value Per Share (mrq) | 483.493 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.64B INR |
| Levered Free Cash Flow (ttm) | 906.23M INR |
Profile of Gland Pharma Limited
| Country | India |
| State | N/A |
| City | Hyderabad |
| Address | Plot No. 11 & 84, TSIIC Phase: IV |
| ZIP | 502307 |
| Phone | 91 84 5569 9999 |
| Website | https://www.glandpharma.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 4752 |
Gland Pharma Limited, a generic injectable-focused company, engages in the development, manufacture, sale, and distribution of pharmaceuticals. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products for various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, as well as anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business-to-business model in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Q&A For Gland Pharma Limited Stock
What is a current GLAND.NS stock price?
Gland Pharma Limited GLAND.NS stock price today per share is 1764 INR.
How to purchase Gland Pharma Limited stock?
You can buy GLAND.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gland Pharma Limited?
The stock symbol or ticker of Gland Pharma Limited is GLAND.NS.
Which industry does the Gland Pharma Limited company belong to?
The Gland Pharma Limited industry is Drug Manufacturers-General.
How many shares does Gland Pharma Limited have in circulation?
The max supply of Gland Pharma Limited shares is 164.71M.
What is Gland Pharma Limited Price to Earnings Ratio (PE Ratio)?
Gland Pharma Limited PE Ratio is 44.02296000 now.
What was Gland Pharma Limited earnings per share over the trailing 12 months (TTM)?
Gland Pharma Limited EPS is 40.07 INR over the trailing 12 months.
Which sector does the Gland Pharma Limited company belong to?
The Gland Pharma Limited sector is Healthcare.